摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyl) [2-(4-bromophenylamino)-4,4-dimethyl-6-oxocyclohex-1-ene]carbodithioate | 1268615-86-6

中文名称
——
中文别名
——
英文名称
(2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyl) [2-(4-bromophenylamino)-4,4-dimethyl-6-oxocyclohex-1-ene]carbodithioate
英文别名
[(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[2-(4-bromoanilino)-4,4-dimethyl-6-oxocyclohexene-1-carbothioyl]sulfanyloxan-2-yl]methyl acetate
(2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyl) [2-(4-bromophenylamino)-4,4-dimethyl-6-oxocyclohex-1-ene]carbodithioate化学式
CAS
1268615-86-6
化学式
C29H34BrNO10S2
mdl
——
分子量
700.626
InChiKey
RXNDFTQAZXNJQP-INFWBLCHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    43
  • 可旋转键数:
    14
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    201
  • 氢给体数:
    1
  • 氢受体数:
    13

反应信息

  • 作为产物:
    描述:
    3-(4-溴苯胺基)-5,5-二甲基环己-2-烯-1-酮二硫化碳2,3,4,6-四乙酰氧基-alpha-D-吡喃葡萄糖溴化物 在 sodium hydroxide 作用下, 以 二甲基亚砜 为溶剂, 反应 24.33h, 以29%的产率得到(2',3',4',6'-tetra-O-acetyl-β-D-glucopyranosyl) [2-(4-bromophenylamino)-4,4-dimethyl-6-oxocyclohex-1-ene]carbodithioate
    参考文献:
    名称:
    丁基和糖基(2-芳基氨基-4,4-二甲基-6-氧代环己基-1-烯)碳二硫代酸酯的合成和X射线分析,以及可能的环化成2-硫代-6,7-二氢-1H-苯并[d] ] [1,3]噻嗪-5(2H)-一衍生物。
    摘要:
    [2-芳氨基-4,4-二甲基-6-氧代-环己-1-烯]丁基碳二硫代酸酯(3a-c),2-硫代-6,7-二氢-1H-苯并[d] [1, 3]噻嗪5(2H)-一衍生物(5a-c)和葡糖基碳二硫代酸酯6a-c以及半乳糖基碳二硫代酸酯7a-c是由烯胺酮衍生物1a-c与二硫化碳反应然后合成分别用正丁基溴化物和α-d-糖基溴化物进行烷基化。二硫化碳的量在反应模式中起重要作用。通过光谱数据和X射线晶体学来阐明合成的化合物的结构。
    DOI:
    10.1016/j.carres.2010.11.005
点击查看最新优质反应信息

文献信息

  • Synthesis, biological evaluation, and molecular docking studies of benzyl, alkyl and glycosyl [2-(arylamino)-4,4-dimethyl-6-oxo-cyclohex-1-ene]carbodithioates, as potential immunomodulatory and immunosuppressive agents
    作者:El Sayed H. El Ashry、Mohammad R. Amer、Omer M. Abdalla、Aly A. Aly、Samreen Soomro、Almas Jabeen、Sobia Ahsan Halim、M. Ahmed Mesaik、Zaheer Ul-Haq
    DOI:10.1016/j.bmc.2012.03.003
    日期:2012.5
    The immunomodulating properties of functionalized [2-(arylamino)-4,4-dimethyl-6-oxo-cyclohex-1-ene] carbodithioates and 6,6-dimethyl-4-(2-(propan-2-ylidene)hydrazinyl)-6,7-dihydro-2H-indazole-3(5H)-thione compounds have been investigated. Four of them, 13, 18, 19 and 20 inhibited PBMC proliferation induced by phytohemagglutinin (PHA) in a dose dependent manner with an IC50 of <= 20 mu M. The Th-1 cytokine, interleukin-2 (IL-2) in PHA/PMA-stimulated peripheral blood mononuclear cells (PBMCs) is significantly inhibited by 13, 19 and 20 with an IC50 of 8.4 +/- 0.4, 5.34 +/- 0.15 and 4.9 +/- 0.7 mu M, respectively. They also inhibited the PMA/lipopolysaccharide-induced proinflammatory cytokines, IL-1 beta and TNF-alpha production in human monocytic leukemia cells (THP-1), by 86%, 46% and 59.2% for IL-1 beta and by 83.8%, 48.2% and 58.7% for TNF-alpha, respectively. Only 20 showed significant suppressive activity against the phagocyte oxidative burst in a dose dependent manner, with an IC50 of 23.8 mu M. LPS-induced nitrites in mouse macrophages were found to be inhibited by compounds 6, 8, 13-15 and 19 with an IC50, which range between 7.7 and 63 mu M. The cytotoxicity for the active compounds was also studied on Rat Wistar Hepatocyte cell line, CC1 and the Mouse Fibroblast cell line 3T3 NIH in the presence of compounds using a standard MTT assay. Furthermore, structural-activity relationship using automated docking software revealed that active compounds 7, 13 and 19, adapted the same binding mode, however the most active compound 20 is found deeply inserted within the ligand binding site of IL-2, as multiple hydrophobic and hydrophilic key interactions stabilize the compound inside the binding site, thus contributing higher activity.[GRAPHICS]. (C) 2012 Elsevier Ltd. All rights reserved.
  • Synthesis and X-ray analysis of butyl and glycosyl (2-arylamino-4,4-dimethyl-6-oxocyclohex-1-ene)carbodithioates and their possible cyclization to 2-thioxo-6,7-dihydro-1H-benzo[d][1,3]thiazin-5(2H)-one derivatives
    作者:El Sayed H. El Ashry、Aly A. Aly、Mohammed R. Amer、Muhammad R. Shah、Seik W. Ng
    DOI:10.1016/j.carres.2010.11.005
    日期:2011.2
    Variety of butyl [2-arylamino-4,4-dimethyl-6-oxo-cyclohex-1-ene]carbodithioates (3a-c), 2-thioxo-6,7-dihydro-1H-benzo[d][1,3]thiazin-5(2H)-one derivatives (5a-c), and the glucosyl carbodithioates 6a-c as well as galactosyl carbodithioates 7a-c have been synthesized from the reaction of enaminone derivatives 1a-c with carbon disulfide followed by the alkylation with n-butyl bromide and alpha-d-glycosyl
    [2-芳氨基-4,4-二甲基-6-氧代-环己-1-烯]丁基碳二硫代酸酯(3a-c),2-硫代-6,7-二氢-1H-苯并[d] [1, 3]噻嗪5(2H)-一衍生物(5a-c)和葡糖基碳二硫代酸酯6a-c以及半乳糖基碳二硫代酸酯7a-c是由烯胺酮衍生物1a-c与二硫化碳反应然后合成分别用正丁基溴化物和α-d-糖基溴化物进行烷基化。二硫化碳的量在反应模式中起重要作用。通过光谱数据和X射线晶体学来阐明合成的化合物的结构。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物